Application Guaranteed Custom Antibodies at Australia’s Lowest Price
Life Research introduces our Custom Antibody Services with pricing starting at $2250 for mAbs and $995 for pAbs all with our Application Guarantee
1st September 2010
Life Research has an extensive range of catalogue antibodies, but for cutting edge research our clients require the option to produce their own custom antibodies. We are excited to be offering our new custom monoclonal and polyclonal antibody production services with the following key features:
- Quality Guaranteed – Test the final product in your lab and confirm that it meets the pre-agreed quality outcomes... if it fails you pay nothing.
- Application Guaranteed Packages – Includes testing and data reports to ensure the antibody produced will meet pre-agreed outcomes in your choice of ELISA and Over-expression WB/IP/IF applications.
- Best Australian Price – Do more research for each dollar of funding by leveraging our access to Australia’s lowest cost antibody production service.
To get more information and to see pricing for each of our application guaranteed packages please select from the Services menu above. To organise a complementary project scoping meeting please Contact Us
Diabetes, Obesity and Metabolic Syndrome Research Products
Life Research Specialises by Offering a New Diabetes Research Area Focus in Partnership with BioVision
08 June, 2010
BioVision offers an impressive range of antibodies and reagents for Diabetes, Obesity and Metabolic Syndrome research. BioVision has released a brand new technically rich 52-page brochure divided into two main sections:
- Signaling Pathways in Diabetes and Obesity
- Lipid Metabolism
The brochure introduces over 400 products categorized under Assay Kits, Antibodies, Proteins & Enzymes and Inhibitors.
An estimated 275 Australians develop diabetes every day. The 2005 Australian AusDiab Follow-up Study (Australian Diabetes, Obesity and Lifestyle Study) showed that 1.7 million Australians have diabetes but that up to half of the cases of type 2 diabetes remain undiagnosed. By 2031 it is estimated that 3.3 million Australians will have type 2 diabetes (Vos et al., 2004).
While treatments for both types of diabetes exist, neither is curable and effective treatments for obesity are yet to be developed. Desire to find cures for diabetes, obesity and related metabolic syndrome are pushing the demand for innovative reagents for research in this area. This is particularly true in Australia where research into diabetes alone has dramatically expanded since 2000:
- In 2009, more than $63 million was expended by the NHMRC on 341 active research grants investigating diabetes - this has grown from just over $10M in 2000 and is expected to grow again in 2010.
- Diabetes Australia Research Trust (DART) has announced funding of approximately $2 million for 27 new projects for 2010 - an increase of 14%.
Life Research is excited to be offering a Research Area category specifically for Diabetes, Obesity & Metabolic Syndrome.
